4/A//SEC Filing
Cole Hugh M 4/A
Accession 0001640455-22-000035
CIK 0001640455other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 8:50 PM ET
Size
5.6 KB
Accession
0001640455-22-000035
Insider Transaction Report
Form 4/AAmended
Cole Hugh M
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-01+85,000→ 85,000 totalExercise: $7.56Exp: 2032-02-01→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]The Stock Option will vest (i) as to 55,000 shares of the Stock Option, quarterly in 16 equal installments following January 1, 2022 and (ii) as to 30,000 shares of the Stock Option, on January 1, 2023.
Documents
Issuer
Jounce Therapeutics, Inc.
CIK 0001640455
Entity typeother
Related Parties
1- filerCIK 0001604646
Filing Metadata
- Form type
- 4/A
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 8:50 PM ET
- Size
- 5.6 KB